Blog

NextEra Energy Partners (NYSE: NEP) generated excellent results during the second quarter despite the market turmoil caused by COVID-19. Underlying the company's strength were its strong contract

As we all know, Apple is one of the most successful companies of all time. Since its initial public offering in 1980, its shares have gone on to appreciate almost 1,000 times over -- and that's not

Garmin (NASDAQ: GRMN) stock has tracked right along with the market so far in 2020, first swooning as the S&P 500 dove in late March and then rallying right back to positive territory in early July

It's been a volatile year in the markets, and the S&P 500's returns are flat year to date. While that's good news for investors who were fearing the worst (a prolonged market crash) in March, 2020's

BP (NYSE: BP), formerly known as British Petroleum, is shaking things up in the middle of a deep industry downturn. On the surface, the changes it's making are good news -- but when you dig in a

I've never been bearish on JPMorgan Chase (NYSE: JPM) long-term, but in the past few months, I've been worried about the kinds of problems the bank might run into in the short term. After all

From what you've heard in the news, you might get the idea that investors who use the Robinhood trading app don't stand a chance of making money. It's true that some day traders use Robinhood as

We've been reading about it for years, but the e-commerce revolution is truly heating up in 2020. Nonstore retail is a category that includes online shopping, and it's growing like crazy. According

Slack (NYSE: WORK) recently filed an antitrust complaint against Microsoft (NASDAQ: MSFT) in the European Union, claiming Microsoft's strategy of bundling Teams into Office 365 is anti-competitive.

Inovio Pharmaceuticals (NASDAQ: INO) is one of the biotech companies everyone is talking about these days. Though the company doesn't have any products on the market, the shares have surged by 717%

Synairgen's (LSE: SNG) stock skyrocketed on Monday amid news that the largely unknown British respiratory therapeutics company had demonstrated in a phase 2 clinical trial that its inhalable drug

As the COVID-19 pandemic rages on, many seniors are facing some tough choices. Should they stop providing child care to their grandchildren? Should they take a leave of absence from work for

There's no way to sugarcoat it: Oil giant ExxonMobil (NYSE: XOM) has had a very, very bad year. Shares are down more than 35% year to date.

Of course, the last few years haven't been all that great

Many cannabis companies have fallen out of favor over the past few months amid growing financial losses and other issues. However, there are a few businesses out there that are not only doing

At some point in their lives, nearly 50% of men will experience hair loss due to stress, genetics, or hormone imbalance. Up to 40% of males over age 40 experience erectile dysfunction (ED). These

Which stocks are best to own during a market crash? To find out, we can look to ones that demonstrated strength in the most recent crash. Often, the winners are those with market leadership. If

When COVID-19 first took hold back in March, the stock market reacted almost instantly, plunging into bear market territory for the first time in over a decade. But stock values have recovered

Many investors believe that stocks will revert to the mean: What goes up will come down, and what goes down will come up. This belief is profoundly untrue. Stocks that have dropped often continue to

Fifth-generation "stealthy" fighter jets, invisible to radar, capable of flying unimpeded into hostile territory to hit their targets and come home safe -- how great is that? Who wouldn't want to

CRISPR gene editing became a big story around 2012, and in the few years that followed, the promise of the technology spurred the founding of several biotechs focused on using it to treat diseases

You could make a pretty good case that any time is a good time to buy shares in big drugmakers if you have a long enough investing horizon. Most major pharmaceutical companies generate lots of cash

The emergence of the COVID-19 pandemic earlier this year has changed everything, from how we live to how we work, and everything in between. Remote work and videoconferencing have combined to cause

Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions.

Here's what you

CRISPR Therapeutics (NASDAQ: CRSP) may be one of the best biotechnology stocks to own in 2020. It's one of a few companies leading the way in gene-editing therapies, a market that the analysts at

Which candidate is winning in the race to develop a vaccine against the novel coronavirus SARS-CoV-2? It depends on whom you ask.

World Health Organization (WHO) chief scientist Soumya Swaminathan